Elroy T. Cantrell

806 total citations
27 papers, 654 citations indexed

About

Elroy T. Cantrell is a scholar working on Cancer Research, Pharmacology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Elroy T. Cantrell has authored 27 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cancer Research, 10 papers in Pharmacology and 9 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Elroy T. Cantrell's work include Carcinogens and Genotoxicity Assessment (14 papers), Toxic Organic Pollutants Impact (9 papers) and Pharmacogenetics and Drug Metabolism (8 papers). Elroy T. Cantrell is often cited by papers focused on Carcinogens and Genotoxicity Assessment (14 papers), Toxic Organic Pollutants Impact (9 papers) and Pharmacogenetics and Drug Metabolism (8 papers). Elroy T. Cantrell collaborates with scholars based in United States. Elroy T. Cantrell's co-authors include David L. Busbee, R. Russell Martin, Charles R. Shaw, Edward Bresnick, G A Warr, Theodore L. McLemore, Naomi R. Wray, Gottfried Kellermann, M E Abreu and David E. Anderson and has published in prestigious journals such as Science, Journal of Clinical Investigation and The Journal of Cell Biology.

In The Last Decade

Elroy T. Cantrell

27 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elroy T. Cantrell United States 14 300 214 209 169 106 27 654
J.R.P. Cabral France 19 281 0.9× 123 0.6× 306 1.5× 205 1.2× 89 0.8× 25 785
Michael D. Stonard United Kingdom 16 113 0.4× 172 0.8× 200 1.0× 286 1.7× 84 0.8× 28 776
LORRAINE C. GRAND United States 7 236 0.8× 61 0.3× 291 1.4× 93 0.6× 224 2.1× 9 885
Georg F. Kahl Germany 16 153 0.5× 211 1.0× 269 1.3× 80 0.5× 373 3.5× 34 820
Sakina E. Eltom United States 14 234 0.8× 191 0.9× 343 1.6× 233 1.4× 256 2.4× 21 856
Tamie Nakajima Japan 13 281 0.9× 393 1.8× 149 0.7× 127 0.8× 149 1.4× 24 683
Wendy Burgess Australia 12 218 0.7× 349 1.6× 271 1.3× 60 0.4× 180 1.7× 19 629
Mieke Luyten‐Kellermann United States 9 134 0.4× 156 0.7× 129 0.6× 61 0.4× 58 0.5× 10 361
Rochelle M. Long United States 14 129 0.4× 198 0.9× 332 1.6× 72 0.4× 94 0.9× 25 694
Franz Kiefer Germany 12 231 0.8× 182 0.9× 337 1.6× 212 1.3× 102 1.0× 22 683

Countries citing papers authored by Elroy T. Cantrell

Since Specialization
Citations

This map shows the geographic impact of Elroy T. Cantrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elroy T. Cantrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elroy T. Cantrell more than expected).

Fields of papers citing papers by Elroy T. Cantrell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elroy T. Cantrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elroy T. Cantrell. The network helps show where Elroy T. Cantrell may publish in the future.

Co-authorship network of co-authors of Elroy T. Cantrell

This figure shows the co-authorship network connecting the top 25 collaborators of Elroy T. Cantrell. A scholar is included among the top collaborators of Elroy T. Cantrell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elroy T. Cantrell. Elroy T. Cantrell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McLemore, Theodore L., R. Russell Martin, Naomi R. Wray, Elroy T. Cantrell, & David L. Busbee. (1981). Reassessment of the relationship between aryl hydrocarbon hydroxylase and lung cancer. Cancer. 48(6). 1438–1443. 13 indexed citations
2.
Busbee, David L., et al.. (1980). Correlation of carcinogen-induced unscheduled DNA synthesis and NAD reduction in fresh human lymphocytes. Cancer Letters. 11(2). 153–160. 7 indexed citations
3.
Tyrer, Harry W., et al.. (1979). Cell sorter analysis of carcinogen metabolites in human tissues.. Journal of Histochemistry & Cytochemistry. 27(1). 508–511. 5 indexed citations
4.
Snodgrass, D. R., Theodore L. McLemore, Naomi R. Wray, et al.. (1979). Induction of aryl hydrocarbon hydroxylase in human peripheral blood lymphocytes by chrysene. Cancer Letters. 7(6). 313–318. 1 indexed citations
5.
McLemore, Theodore L., R. Russell Martin, Naomi R. Wray, Elroy T. Cantrell, & David L. Busbee. (1978). Dissociation between aryl hydrocarbon hydroxylase activity in cultured pulmonary macrophages and blood lymphocytes from lung cancer patients.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(11 Pt 1). 3805–11. 21 indexed citations
6.
McLemore, Theodore L., R. Russell Martin, Naomi R. Wray, et al.. (1978). Analysis of aryl hydrocarbon hydroxylase activity in human lung tissue, pulmonary macrophages, and blood lymphocytes. Cancer. 41(6). 2292–2300. 33 indexed citations
7.
Busbee, David L., et al.. (1978). Metabolism of benzo(a)pyrene in animals with high aryl hydrocarbon hydroxylase levels and high rates of spontaneous cancer. Cancer Letters. 4(2). 61–67. 9 indexed citations
8.
McLemore, Theodore L., et al.. (1978). A human plasma component that binds benzo(A)pyrene. Cancer. 42(6). 2733–2737. 7 indexed citations
9.
Cantrell, Elroy T., et al.. (1978). Steroid hydroxylase induction in cultured human lymphocytes: Effects of the menstrual cycle. Steroids. 31(1). 1–7. 11 indexed citations
10.
McLemore, Theodore L., et al.. (1977). Aryl hydrocarbon hydroxylase activity in pulmonary macrophages and lymphocytes from lung cancer and noncancer patients.. PubMed. 37(4). 1175–81. 69 indexed citations
11.
McLemore, Theodore L., et al.. (1977). Comparison of Aryl Hydrocarbon Hydroxylase Induction in Cultured Blood Lymphocytes and Pulmonary Macrophages. Journal of Clinical Investigation. 60(5). 1017–1024. 17 indexed citations
12.
Cantrell, Elroy T., et al.. (1976). Aryl hydrocarbon hydroxylase and 16?-hydroxylase in cultured human lymphocytes. Biochemical Genetics. 14(7-8). 671–685. 21 indexed citations
13.
Cantrell, Elroy T., et al.. (1975). Metabolism of diphenyloxazole (PPO) by mouse liver microsomes. Life Sciences. 17(3). 317–321. 13 indexed citations
14.
Busbee, David L., et al.. (1975). Induction of aryl hydrocarbon hydroxylase in Ambystoma tigrinum.. PubMed. 50(1). 33–6. 13 indexed citations
15.
Cantrell, Elroy T., G A Warr, David L. Busbee, & R. Russell Martin. (1973). Induction of Aryl Hydrocarbon Hydroxylase in Human Pulmonary Alveolar Macrophages by Cigarette Smoking. Journal of Clinical Investigation. 52(8). 1881–1884. 117 indexed citations
16.
Cantrell, Elroy T. & David L. Busbee. (1973). Induction of aryl hydrocarbon hydroxylase in human lymphocytes and pulmonary alveolar macrophages - a comparison. Life Sciences. 13(12). 1649–1654. 35 indexed citations
17.
Cantrell, Elroy T. & Edward Bresnick. (1972). BENZPYRENE HYDROXYLASE ACTIVITY IN ISOLATED PARENCHYMAL AND NONPARENCHYMAL CELLS OF RAT LIVER. The Journal of Cell Biology. 52(2). 316–321. 52 indexed citations
18.
Busbee, David L., Charles R. Shaw, & Elroy T. Cantrell. (1972). Aryl Hydrocarbon Hydroxylase Induction in Human Leukocytes. Science. 178(4058). 315–316. 92 indexed citations
19.
Black, Owen, et al.. (1971). Effects of 3-methylcholanthrene administration on the proteins of endoplasmic reticulum. Biochemical Pharmacology. 20(11). 2989–2998. 3 indexed citations
20.
Cantrell, Elroy T. & Edward Bresnick. (1971). Evidence for type II induction of microsomal enzymes by β-naphthoflavone in rat liver preparations. Life Sciences. 10(20). 1195–1200. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026